Cargando…
New Agents in Development for Sepsis: Any Reason for Hope?
Sepsis is a syndrome which is defined as a dysregulated host response to infection leading to organ failure. Since it remains one of the leading causes of mortality worldwide, numerous drug candidates have already been tested, and continue to be developed, as potential adjunct therapies. Despite con...
Autores principales: | Vignon, Philippe, Laterre, Pierre-François, Daix, Thomas, François, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502152/ https://www.ncbi.nlm.nih.gov/pubmed/32951149 http://dx.doi.org/10.1007/s40265-020-01402-z |
Ejemplares similares
-
Ex situ machine preservation of donor livers for transplantation: HOPE for all?
por: van Leeuwen, O B, et al.
Publicado: (2021) -
Systematic review and meta‐analysis: Is there any role for antioxidant therapy for pain in chronic pancreatitis
por: Mohta, Srikant, et al.
Publicado: (2020) -
Perspective on optimizing clinical trials in critical care: how to puzzle out recurrent failures
por: François, Bruno, et al.
Publicado: (2016) -
Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020) -
New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
por: Saraff, Vrinda, et al.
Publicado: (2020)